Our Pricing

Understanding Tirzepatide Monthly Cost UK: Complete Budgeting Guide

Published on: June 03, 2026

Planning your tirzepatide monthly cost UK budget requires understanding dose escalation, treatment duration, and pharmacy pricing structures. At Cured Pharmacy, Mounjaro (tirzepatide) starts from £124.99 per month with transparent upfront pricing, helping you budget confidently for your weight loss journey without hidden consultation fees or surprise charges.

How Tirzepatide Monthly Costs Are Structured in the UK

Your tirzepatide monthly cost UK depends primarily on your prescribed maintenance dose, which is reached through gradual escalation over 16-20 weeks. Treatment typically begins at 2.5mg weekly for four weeks, increasing to 5mg, then 7.5mg, 10mg, 12.5mg, and finally 15mg if clinically appropriate [1]. Each KwikPen contains four weekly doses, meaning one pen covers one month of treatment.

At Cured Pharmacy, Mounjaro is priced at £124.99 per month, covering your medication, UK prescriber assessment, and discreet home delivery. Unlike some providers who advertise lower entry prices but add consultation fees or tiered pricing structures, our transparent model shows the full monthly cost before you begin your clinical assessment [2].

The SURPASS-2 trial demonstrated that patients on 15mg tirzepatide achieved an average 22.5% body weight reduction over 72 weeks, with most weight loss occurring in the first 40 weeks [1]. This means your monthly investment delivers compounding results throughout your treatment programme, with costs remaining stable as you reach maintenance dosing.

Tirzepatide vs Semaglutide: Monthly Cost Comparison

When budgeting your weight loss treatment, understanding how tirzepatide compares to semaglutide-based alternatives helps you make informed financial decisions. Both medications are GLP-1 receptor agonists licensed by the MHRA for chronic weight management, but tirzepatide additionally activates GIP receptors, producing dual-pathway metabolic effects [3].

Wegovy (semaglutide) starts from £135.00 per month at Cured Pharmacy, making it a lower-cost entry point. However, head-to-head trials show tirzepatide produces superior weight loss outcomes — in the SURPASS-2 study, 15mg tirzepatide delivered 5.5kg greater average weight reduction compared to 1mg semaglutide over 40 weeks [1]. Your UK prescriber will assess which medication offers the best clinical and financial value based on your weight loss goals, medical history, and budget considerations.

Saxenda (liraglutide), available from £135.00 per month, requires daily injections rather than weekly dosing. Whilst this represents the lowest monthly cost among injectable GLP-1 treatments, clinical trials show smaller average weight reductions compared to tirzepatide — typically 5-7% body weight versus up to 22.5% with tirzepatide's highest dose [4]. Your treatment choice should balance monthly affordability with expected outcomes and injection frequency preferences.

Long-Term Budget Planning for Tirzepatide Treatment

Most patients remain on tirzepatide for 12-18 months to achieve and stabilise their weight loss goals, though treatment duration varies based on individual response and clinical need [2]. At £135.00 per month, a 12-month treatment programme costs approximately £135.00 whilst an 18-month course totals around £135.00. These figures assume consistent maintenance dosing after the initial escalation period.

Your UK prescriber will schedule regular reviews every 3-6 months to assess treatment response, adjust dosing if needed, and determine when you've reached your clinical goals. Some patients may transition to lower maintenance doses or discontinue treatment once they've achieved sustainable weight loss and established healthy lifestyle habits, potentially reducing long-term costs [3].

Factors That Affect Your Tirzepatide Monthly Cost UK

Several variables influence your actual monthly expenditure beyond the base medication price. Dose escalation means your first 16-20 weeks may involve different pricing if your pharmacy charges per dose rather than per pen — at Cured Pharmacy, our £135.00 monthly price covers all dose strengths, eliminating cost uncertainty during escalation [2].

Delivery frequency also impacts budgeting. Some patients prefer monthly deliveries (one pen per month), whilst others choose quarterly shipments (three pens) to reduce delivery frequency. Cured Pharmacy offers both options with the same per-pen pricing, and our discreet packaging ensures privacy regardless of delivery schedule.

Additional costs to consider include glucose monitoring for patients with diabetes, routine blood tests recommended by your prescriber, and potential adjustments to other medications as your weight decreases. Your UK clinical team will discuss these considerations during your initial assessment, helping you budget comprehensively for your treatment journey [4].

Hidden Costs to Watch For When Comparing Providers

When researching tirzepatide monthly cost UK across different pharmacies, scrutinise the total price structure. Some providers advertise low medication costs but charge separate consultation fees (typically £135.00-50), prescription fees, or delivery charges that significantly increase your actual monthly expenditure. At Cured Pharmacy, our £135.00 price includes your UK prescriber assessment, prescription, medication, and delivery — the price you see is what you pay.

Subscription models require particular attention. Whilst automatic monthly deliveries offer convenience, ensure you can pause or cancel without penalties if you need to adjust treatment. Our transparent pricing model gives you full control over your treatment schedule without lock-in contracts or cancellation fees.

Is Tirzepatide Worth the Monthly Investment?

Clinical trial data provides objective context for evaluating tirzepatide's cost-effectiveness. In the SURMOUNT-1 trial, patients without diabetes achieved average weight reductions of 15.0% (5mg), 19.5% (10mg), and 20.9% (15mg) over 72 weeks [3]. For a 100kg patient, this translates to 15-21kg average weight loss — substantially higher than lifestyle interventions alone, which typically produce 3-5% reductions.

Beyond the scale, tirzepatide treatment in clinical trials has shown improvements in cardiovascular risk markers, blood pressure, lipid profiles, and inflammatory markers [1]. These metabolic benefits may reduce long-term health costs associated with obesity-related conditions, though individual results vary and require ongoing clinical monitoring.

Your UK prescriber will help you assess whether tirzepatide's monthly cost aligns with your weight loss goals and financial circumstances. For some patients, starting with lower-cost alternatives like orlistat (from £135.00 per month) or liraglutide-based treatments provides a more accessible entry point, with the option to escalate to tirzepatide if initial treatments don't achieve desired results [4].

How to Access Tirzepatide at Cured Pharmacy

Accessing tirzepatide through Cured Pharmacy begins with a free online clinical assessment that takes under three minutes to complete. You'll answer questions about your weight history, medical conditions, current medications, and weight loss goals, allowing our UK-registered prescribers to determine if tirzepatide is clinically appropriate and safe for you.

If approved, your prescription is issued electronically and sent to our dispensary, where our GPhC-registered pharmacy team (Superintendent Pharmacist: Tarun Kumar, GPhC 2233073) prepares your medication for discreet delivery. Most orders are dispatched within 24-48 hours, arriving in unmarked packaging to protect your privacy. Your first pen will be the 2.5mg starting dose, with subsequent deliveries automatically adjusted to your escalation schedule unless you request changes.

Ongoing clinical support is included throughout your treatment. You can message our UK prescribers with questions about side effects, dose adjustments, or treatment concerns at no additional cost. Regular reviews ensure your treatment remains safe and effective, with dose modifications made based on your individual response and tolerability [2].

What Happens During Your Clinical Assessment

Your UK prescriber will review your BMI, weight loss history, previous treatments tried, and any contraindications to tirzepatide. NICE guidelines recommend GLP-1 receptor agonists for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities [4]. Your prescriber will also screen for conditions that may affect tirzepatide safety, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

If tirzepatide isn't clinically appropriate for you, your prescriber will explain why and discuss alternative treatments that may better suit your medical profile and budget. This might include semaglutide-based options, liraglutide, or non-injectable treatments like orlistat, ensuring you have access to effective weight management regardless of your starting point.

Managing Side Effects and Treatment Costs

Gastrointestinal side effects — particularly nausea, diarrhoea, and constipation — are the most commonly reported reactions to tirzepatide, typically occurring during dose escalation and diminishing as your body adapts [1]. Most patients manage these symptoms through dietary modifications (smaller meals, avoiding high-fat foods) without additional costs, though some may purchase over-the-counter remedies like loperamide or anti-nausea medication.

Your UK prescriber may recommend slowing your dose escalation if side effects become troublesome, which can extend your time on lower doses and potentially reduce monthly costs temporarily. This individualised approach ensures treatment remains tolerable whilst maintaining clinical effectiveness. Severe or persistent side effects should always be reported to your prescriber, who can assess whether continuing treatment is appropriate [3].

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Whilst these complications may incur additional medical costs if they occur, clinical trial data shows they affect a small minority of patients [1]. Your prescriber will monitor for warning signs during regular reviews and adjust treatment if risk factors emerge.

When to Consider Stopping Treatment

NICE guidance suggests reviewing weight loss treatments after 12 months and considering discontinuation if clinically appropriate [4]. If you've achieved your weight loss goals, established sustainable lifestyle habits, and maintained stable weight for several months, your prescriber may recommend gradually stopping tirzepatide to assess whether you can maintain results without ongoing medication.

Conversely, if you haven't achieved at least 5% weight loss after 12 weeks on a therapeutic dose, your prescriber will reassess whether tirzepatide is the right treatment for you. This clinical checkpoint prevents unnecessary expenditure on treatments that aren't delivering expected results, potentially redirecting you toward more suitable alternatives or additional support [2].

Scientific References

1. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): A Randomised, Open-Label, Parallel-Group, Phase 3 Trial. The Lancet, 398(10295), 64–77. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE Guideline. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including diet, exercise, and treatment adherence.